Logo image of BHIL

BENSON HILL INC (BHIL) Stock Fundamental Analysis

USA - NASDAQ:BHIL - US0824902029 - Common Stock

0.249 USD
-0.17 (-41.19%)
Last: 3/26/2025, 8:00:02 PM
0.17 USD
-0.08 (-31.73%)
After Hours: 3/26/2025, 8:00:02 PM
Fundamental Rating

2

Overall BHIL gets a fundamental rating of 2 out of 10. We evaluated BHIL against 87 industry peers in the Food Products industry. BHIL may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, BHIL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BHIL has reported negative net income.
In the past year BHIL has reported a negative cash flow from operations.
In the past 5 years BHIL always reported negative net income.
In the past 5 years BHIL always reported negative operating cash flow.
BHIL Yearly Net Income VS EBIT VS OCF VS FCFBHIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -50M -100M

1.2 Ratios

BHIL has a Return On Assets of -73.99%. This is amonst the worse of the industry: BHIL underperforms 87.91% of its industry peers.
BHIL's Return On Equity of -379.14% is on the low side compared to the rest of the industry. BHIL is outperformed by 87.91% of its industry peers.
Industry RankSector Rank
ROA -73.99%
ROE -379.14%
ROIC N/A
ROA(3y)-30.36%
ROA(5y)-33.1%
ROE(3y)-83.39%
ROE(5y)-77.15%
ROIC(3y)N/A
ROIC(5y)N/A
BHIL Yearly ROA, ROE, ROICBHIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

With a Gross Margin value of 5.33%, BHIL is not doing good in the industry: 81.32% of the companies in the same industry are doing better.
BHIL's Gross Margin has declined in the last couple of years.
BHIL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.76%
GM growth 5Y-43.1%
BHIL Yearly Profit, Operating, Gross MarginsBHIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

BHIL does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHIL has less shares outstanding than it did 1 year ago.
The debt/assets ratio for BHIL is higher compared to a year ago.
BHIL Yearly Shares OutstandingBHIL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
BHIL Yearly Total Debt VS Total AssetsBHIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

BHIL has an Altman-Z score of -6.14. This is a bad value and indicates that BHIL is not financially healthy and even has some risk of bankruptcy.
BHIL's Altman-Z score of -6.14 is on the low side compared to the rest of the industry. BHIL is outperformed by 84.62% of its industry peers.
A Debt/Equity ratio of 3.12 is on the high side and indicates that BHIL has dependencies on debt financing.
BHIL has a worse Debt to Equity ratio (3.12) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF N/A
Altman-Z -6.14
ROIC/WACCN/A
WACC9.33%
BHIL Yearly LT Debt VS Equity VS FCFBHIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

BHIL has a Current Ratio of 2.21. This indicates that BHIL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.21, BHIL is in the better half of the industry, outperforming 67.03% of the companies in the same industry.
BHIL has a Quick Ratio of 1.74. This is a normal value and indicates that BHIL is financially healthy and should not expect problems in meeting its short term obligations.
BHIL has a Quick ratio of 1.74. This is amongst the best in the industry. BHIL outperforms 80.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.74
BHIL Yearly Current Assets VS Current LiabilitesBHIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.20% over the past year.
Looking at the last year, BHIL shows a very negative growth in Revenue. The Revenue has decreased by -49.19% in the last year.
BHIL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 156.06% yearly.
EPS 1Y (TTM)14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
Revenue 1Y (TTM)-49.19%
Revenue growth 3Y100.08%
Revenue growth 5Y156.06%
Sales Q2Q%-69.84%

3.2 Future

Based on estimates for the next years, BHIL will show a very strong growth in Earnings Per Share. The EPS will grow by 23.04% on average per year.
BHIL is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -33.44% yearly.
EPS Next Y40.84%
EPS Next 2Y34.39%
EPS Next 3Y23.04%
EPS Next 5YN/A
Revenue Next Year-71.85%
Revenue Next 2Y-52.14%
Revenue Next 3Y-33.44%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHIL Yearly Revenue VS EstimatesBHIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
BHIL Yearly EPS VS EstimatesBHIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BHIL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BHIL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHIL Price Earnings VS Forward Price EarningsBHIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHIL Per share dataBHIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as BHIL's earnings are expected to grow with 23.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.39%
EPS Next 3Y23.04%

More info and screens

0

5. Dividend

5.1 Amount

BHIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BENSON HILL INC

NASDAQ:BHIL (3/26/2025, 8:00:02 PM)

After market: 0.17 -0.08 (-31.73%)

0.249

-0.17 (-41.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners17.2%
Inst Owner Change0%
Ins Owners8.84%
Ins Owner Change0%
Market Cap1.52M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.82%
Min EPS beat(2)-67.13%
Max EPS beat(2)-30.51%
EPS beat(4)1
Avg EPS beat(4)-40.73%
Min EPS beat(4)-67.24%
Max EPS beat(4)1.96%
EPS beat(8)3
Avg EPS beat(8)-18.22%
EPS beat(12)6
Avg EPS beat(12)-8.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.88%
Min Revenue beat(2)-14.5%
Max Revenue beat(2)36.26%
Revenue beat(4)2
Avg Revenue beat(4)6.8%
Min Revenue beat(4)-25.47%
Max Revenue beat(4)36.26%
Revenue beat(8)5
Avg Revenue beat(8)7.9%
Revenue beat(12)7
Avg Revenue beat(12)-2.44%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.07
EV/EBITDA N/A
EPS(TTM)-21.02
EYN/A
EPS(NY)-4.75
Fwd EYN/A
FCF(TTM)-6.91
FCFYN/A
OCF(TTM)-6.55
OCFYN/A
SpS33.65
BVpS4.39
TBVpS3.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.99%
ROE -379.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.33%
FCFM N/A
ROA(3y)-30.36%
ROA(5y)-33.1%
ROE(3y)-83.39%
ROE(5y)-77.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.76%
GM growth 5Y-43.1%
F-Score3
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.42%
Cap/Sales 1.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 1.74
Altman-Z -6.14
F-Score3
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)124.08%
Cap/Depr(5y)136.84%
Cap/Sales(3y)13.82%
Cap/Sales(5y)13.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
EPS Next Y40.84%
EPS Next 2Y34.39%
EPS Next 3Y23.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-49.19%
Revenue growth 3Y100.08%
Revenue growth 5Y156.06%
Sales Q2Q%-69.84%
Revenue Next Year-71.85%
Revenue Next 2Y-52.14%
Revenue Next 3Y-33.44%
Revenue Next 5YN/A
EBIT growth 1Y11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.41%
EBIT Next 3Y24.07%
EBIT Next 5YN/A
FCF growth 1Y66.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.14%
OCF growth 3YN/A
OCF growth 5YN/A